Coagulation analyser market to hit $5.34b by 2030

It is driven by aging population and rise in blood disorders

The global coagulation analyser market is growing steadily, rising from $3.52b in 2024 to $3.77b in 2025, as per MarketsandMarkets report. It is projected to reach $5.34b by 2030, with a compound annual growth rate (CAGR) of 7.2%.

The growth is fuelled by the increasing prevalence of blood clotting disorders like hemophilia and deep vein thrombosis.

Additionally, an aging population and higher rates of chronic diseases are also driving demand for faster and more accurate diagnostic tools.

The report said that hospitals and labs are turning to automated analysers to improve efficiency and reduce wait times.

Point-of-care testing is also gaining ground as it speeds up decision-making in critical situations.

In emerging markets, investments in healthcare infrastructure and new technologies—such as AI—are opening up further opportunities.

In 2024, Asia Pacific held the largest market share. Key drivers include a high number of blood-related disorders, rising surgeries, and improved healthcare systems in countries like China, Japan, and Australia.

China's aging population is also a major factor. A 2023 report showed that 216.76 million people aged over 65 and nearly 297 million aged over 60, making up 21.1% of the total population. Older adults are more prone to blood disorders, increasing the need for regular coagulation testing.